Summary: Getlabs and Inocras have partnered to enhance patient testing convenience and efficiency; Getlabs enables patients to book lab sample collections from home, while Inocras offers comprehensive genetic insights into cancer and rare diseases through whole genome sequencing tests.

Takeaways:

  1. The partnership between Getlabs and Inocras aims to provide patients with greater accessibility and convenience in accessing whole genome sequencing tests. 
  2. Inocras’ whole genome sequencing test is designed to offer deep insights into patients’ genetic composition, providing comprehensive analyses for cancer and rare diseases. 
  3. By allowing patients to schedule at-home sample collections, the collaboration streamlines the testing process and eliminates the need for clinic visits.

At-home diagnostics collection provider Getlabs has joined forces with Inocras, an AI-driven whole genome testing company seeking to empower patients with critical genetic insights for cancer and rare diseases, to provide patients with enhanced testing convenience and efficiency.

The Getlabs and Inorcras Partnership

Getlabs’ mission is to redesign the lab experience around patients, allowing them to book lab sample collections conveniently and comfortably from their homes, creating greater accessibility and convenience in their care process. Meanwhile, Inocras provides whole genome sequencing tests, which deliver patients deep insights into their cancer and rare disease by providing comprehensive and detailed analyses of an individual’s genetic composition. 

Inocras’ digital service platform is designed to offer patients a seamless end-to-end experience, allowing them to request a test order, book at-home sample collections with the help of the Getlabs partnership, and receive test results with genetic counseling support.

“We are thrilled to embark on this partnership with Inocras,” says Kyle Michelson, CEO of Getlabs. “Together, we are empowering patients to take control of their health journey by providing them with access to lab collection services without having to travel to or sit in a waiting room.”

Further reading: Getlabs to Add GRAIL’s Multi-Cancer Early Detection Test for Home Diagnostic Services

Creating More Convenient and Efficient Testing

Both organizations are looking to establish a service that helps create for patients a future where access to whole genome sequencing is easier and more convenient than ever before.

“We are thrilled to launch our whole genome diagnostics products, CancerVision and RareVision,” says Rebecca Jang, Inocras chief strategy officer. “They will provide a more holistic view on patients’ disease and health, presenting not only commonly known mutations but also ultra rare and complicated mutations. Patients can get cutting-edge diagnostics through our patient-centric digital service platform. Our partnership with Getlabs is one of many important steps in bringing patients the best experience possible.”